Moreover, a non-coding variant upregulating plasma cell expression of CEP120, another CPAP-associated centriole elongation activator and appendage assembly factor [53, 54], has recently been shown to increase MM susceptibility [55]. This evidence concerns the gene CEP120 and Miyoshi myopathy.